Skip to main content

Darwin Global Management, Ltd.

SEC CIK
0001839209
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
9
−3 vs. Q1 2024
Portfolio value
$859.5M
+$108.3M (+14.4%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Darwin Global Management, Ltd. in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
CYTKCytokinetics IncCOM NEW4,575,558$246.1M28.6%+4,575,558NewHistory
INSMINSMED IncCOM PAR $.013,541,095$237.1M27.6%+3,541,095NewHistory
PCVXVaxcyte, Inc.COM2,080,946$163.9M19.1%−669,858−24.4%ReducedHistory
GERNGeron CorpCOM23,915,480$106.2M12.4%+23,915,480NewHistory
KROSKeros Therapeutics, Inc.COM1,525,902$68.8M8.0%+89,952+6.3%AddedHistory
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW325,140$14.3M1.7%+325,140NewHistory
SYRESpyre Therapeutics, Inc.COM NEW452,040$10.3M1.2%−21,160−4.5%ReducedHistory
Avidity Biosciences, Inc.05370A108COM200,000$8.11M0.9%+200,000New–
ELEVElevation Acquisition Group Inc.COM1,916,290$4.81M0.6%−416,638−17.9%ReducedHistory

Sold out since Q1 2024 (8)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Darwin Global Management, Ltd. sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
NUVLNuvalent, Inc.COM1,436,964$107.9M14.4%History
BHVNBiohaven Ltd.COM1,476,974$80.8M10.8%History
ALPNAlpine Immune Sciences, Inc.COM1,982,016$78.6M10.5%History
BEAMBeam Therapeutics Inc.COM2,119,598$70.0M9.3%History
APGEApogee Therapeutics, Inc.COM832,198$55.3M7.4%History
XNCRXencor IncCOM1,109,650$24.6M3.3%History
TRMLTourmaline Bio, Inc.COM465,000$10.6M1.4%History
MRKMerck & Co., Inc.Stock79,600$10.5M1.4%History